Company: OXLCZ
Filing Date: 2025-11-05
Form Type: N-CSRS
Source: 0001213900-25-106331
Chunk: 54

Company: Oxford Lane Capital Corp.
Filing Date: 2025-11-05
Form: N-CSRS
Chunk 54
---
                  |     | $           | 2,753,755 |   |     | $           | 2,015,175 |   |     | $           | 2,271,094 |   |     | $        | 7,040,024 |   |

____________ (1)Stated interest is composed of distributions declared and paid of approximately $7.0 million for the six months ended September 30, 2025. (2)Represents the weighted average effective rate for each respective series of Term Preferred Shares. (3)Totals may not sum due to rounding.

47 OXFORD LANE CAPITAL CORP.
NOTES TO FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited) NOTE 9. BORROWINGS NOTES PAYABLE — 6.75% UNSECURED NOTES DUE 2031 On March 16, 2021, the Fund completed an underwritten public offering, including the full exercise of the underwriters’ 30 -dayoverallotment option, of approximately $ 100.0million in aggregate principal amount of 6.75% Unsecured Notes due 2031 (the “6.75% Notes”). The 6.75% Notes will mature on March 31, 2031 and may be redeemed in whole or in part at any time or from time to time at the Fund’s option on or after March 16, 2024. The 6.75% Notes bear interest at a rate of 6.75% per year payable quarterly on March 31, June 30, September 30, and December 31, of each year, commencing June 30, 2021. The aggregate accrued interest payable on the 6.75% Notes as of September 30, 2025 was approximately $18,750. As of September 30, 2025, the Fund had unamortized deferred debt issuance costs of approximately $2.0 million, relating to the 6.75% Notes. The deferred debt issuance costs are being amortized over the term of the 6.75% Notes and are included in interest expense in the statement of operations. The effective annualized interest rate for the six months ended September 30, 2025 was approximately 7.09%. The interest expense paid for the six months ended September 30, 2025 was approximately $3.4 million. NOTES PAYABLE — 5.